Nanoform Finland (private company)

See something wrong or missing? Let us know
Offices:
Helsinki
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.

Companies with similar profile to Nanoform Finland:

CompanyCriteria
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Cavidi
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Mentis Cura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Oncoinvent
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Vaccibody
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden ITBMed
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Aurealis Pharma
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Glucostratus (Mendor)
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Ilmarinen
  • Total raised in a similar range: 10M+ USD
Norway Cytovation
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B